Creative Planning’s Cytori Therapeutics Inc Series S Warrant CYTXZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-16,200
Closed – – 2164
2019
Q2
$0 Hold
16,200
– – ﹤0.01% 2169
2019
Q1
$0 Hold
16,200
– – ﹤0.01% 2126
2018
Q4
$0 Hold
16,200
– – ﹤0.01% 2187
2018
Q3
$0 Hold
16,200
– – ﹤0.01% 2211
2018
Q2
$0 Buy
+16,200
New +$700 ﹤0.01% 2216

Creative Planning's CYTXZ Position: Q3 2019 in Review

Creative Planning sold out of Cytori Therapeutics Inc Series S Warrant (CYTXZ) in Q3 2019, closing a stake of 16,200 shares.

Creative Planning first reported a position in CYTXZ in Q2 2018 and held it in 5 quarters. The position peaked at $0 in Q2 2019. 0 funds tracked by Wall St. Rank hold CYTXZ as of Q3 2019.

  • Creative Planning reported no remaining Cytori Therapeutics Inc Series S Warrant position as of Q3 2019 after selling out during the quarter.
  • Creative Planning sold 16,200 Cytori Therapeutics Inc Series S Warrant shares in Q3 2019.
  • Creative Planning first reported a position in Cytori Therapeutics Inc Series S Warrant in Q2 2018 and held it in 5 quarters.
  • Creative Planning's Cytori Therapeutics Inc Series S Warrant position peaked at $0 in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Cytori Therapeutics Inc Series S Warrant as of Q3 2019.

Based on Creative Planning's 13F filing for Q3 2019, filed 1 Nov 2019.